Errol B Desouza is Director of CATALYST BIOSCIENCES, INC.. Currently has a direct ownership of 29,801 shares of CBIO, which is worth approximately $0. The most recent transaction as insider was on Oct 01, 2021, when has been sold 3,588 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.8K
0% 3M change
0% 12M change
Total Value Held $0

ERROL B DESOUZA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2021
BUY
Grant, award, or other acquisition
-
3,588 Added 10.75%
29,801 Common Stock
Jul 01 2021
BUY
Grant, award, or other acquisition
-
3,406 Added 11.5%
26,213 Common Stock
Apr 01 2021
BUY
Grant, award, or other acquisition
-
2,926 Added 11.37%
22,807 Common Stock
Jan 05 2021
BUY
Grant, award, or other acquisition
-
2,129 Added 9.67%
19,881 Common Stock
Oct 01 2020
BUY
Grant, award, or other acquisition
-
3,125 Added 14.97%
17,752 Common Stock

Also insider at

CYCN
Cyclerion Therapeutics, Inc. Healthcare
RPRX
Royalty Pharma plc Healthcare
ALEC
Alector, Inc. Healthcare
EBD

Errol B Desouza

Director
New York, NY

Track Institutional and Insider Activities on CBIO

Follow CATALYST BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CBIO shares.

Notify only if

Insider Trading

Get notified when an Catalyst Biosciences, Inc. insider buys or sells CBIO shares.

Notify only if

News

Receive news related to CATALYST BIOSCIENCES, INC.

Track Activities on CBIO